FDAs Declaratory Order : FDAs 13-page order describes the process that FDA undertook to come to this conclusion and explains that FDA obtained information both from the manufacturer (Novo Nordisk) as well as from patients, health care providers, and others, including compounders
Additionally, our capacity to monitor temporal changes and establish causal relationships across the gut-brain-microbiome axis is further complicated by the absence of longitudinal, mechanistic, and multi-omics studies [31,32]
Due to high demand and shortages, some patients access compounded semaglutide or compounded tirzepatide
Accessing supplies whilst travelling: If medication is lost, damaged, or runs out during UK travel, contact a local GP surgery or NHS 111 for advice